Dr. Sulaiman Al Habib Medical Services Group revenue and financials
SAR 228.90Change from previous close: +0.18%Absolute change: +SAR 0.40
In the fiscal year ended December 2025, Dr. Sulaiman Al Habib Medical Services Group reported revenue of SAR 13.71B (+22.38% year over year). Net income was SAR 2.4B, a net margin of 17.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +22.38%
- 2025 vs 2024
- Net income growth
- +3.72%
- 2025 vs 2024
- Net margin
- 17.5%
- 2024: 20.7%
Financial data
Amounts in millions of SAR; per-share values in SAR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 3,402 | 2,970 | 3,244 | 2,844 | 2,183 |
| Depreciation and amortization | 672 | 421 | 313 | 309 | 315 |
| Capital expenditure | -2,983 | -3,829 | -3,497 | -1,513 | -1,254 |
| Investing cash flow | -2,970 | -3,775 | -3,487 | -1,939 | -1,248 |
| Financing cash flow | -1,041 | 1,075 | 116 | -801 | -631 |
| Dividends paid | -1,663 | -1,642 | -1,435 | -1,138 | -945 |
| Debt issued | 1,225 | 3,004 | 1,930 | 432 | — |
| Debt repaid | -158 | -158 | -229 | — | — |
| Net change in cash | -609 | 270 | -127 | 103 | 305 |
| Free cash flow | 419 | -858 | -253 | 1,330 | 929 |
| Levered free cash flow | -1,073 | -2,118 | -1,239 | 592 | 284 |
